Clinical trial
Abatacept in ANCA Associated Vasculitis
NCT00482066 · Imperial College London, Other · Terminated
Key facts
| NCT number | NCT00482066 |
|---|---|
| Title | Abatacept in ANCA Associated Vasculitis |
| Official title | A Pilot Study Examining the Effect of Abatacept in ANCA Associated Vasculitis |
| Acronym | ABAVAS |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | ANCA-associated Vasculitis |
| Intervention type | Drug |
| Interventions | Abatacept (Orencia) |
| Enrollment | 7 |
| Start date | Nov 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 4, 2007 |
| Last update posted | May 29, 2015 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: